Kollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M. Super-disintegrants and dissolution enhancers.
|
|
- Janis Sims
- 5 years ago
- Views:
Transcription
1 Kollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M Super-disintegrants and dissolution enhancers.
2 2 The Preface New: 4 dimensions of Kollidon CL standard, fine (CL-F), superfine (CL-SF) and micronized (CL-M) for your individual needs. Kollidon is well known as a universal excipient range since more than 60 years. Kollidon CL, the crosslinked PVP, is not only one of the three super-disintegrants. Moreover, Kollidon CL accelerates the dissolution and the bioavailability due to its power to form complexes with many insoluble actives. The disintegration of a tablet can be regarded as the initial step in terms of bioavailability and pharmacological action of the active substance. To achieve rapid disintegration, a disintegrant normally has to be added to the tablet formulation. The insoluble grades of Kollidon are widely used in the pharmaceuticals industry for this purpose. Furthermore, their use as pharmaceutical excipients is triggered by their ability to hydrophilize insoluble drugs, to stabilize suspensions and to form complexes, as well as by their adsorptive properties. BASF supplies Kollidon CL, Kollidon CL-F and Kollidon CL-SF as disintegrants for the pharmaceutical industry. Kollidon CL-M is usually used as a suspension stabilizer. Trademarks are owned by BASF Aktiengesellschaft Dissolution of acetylsalicylic acid tablets dissolved drug [%] % Kollidon CL without Kollidon CL time [min]
3 The Preface 3 The theory of disintegration of a tablet 1. Disintegrants are very hydrophilic. water 2. Spherical particles are uniformly distributed in the tablet. water 3. They swell during contact with water or other liquids. water 4. They significantly increase volume and disintegrate the tablet. The Market Trends Over the past few years, there has been a trend towards highly potent actives (HPAPI) and, as a consequence, a trend towards smaller tablets. The growth rate of 19 % for HPAPIs underlines the strong market need for potent disintegrants for these applications. These smaller tablets usually require disintegrants of much smaller particle size to guarantee content uniformity and to prevent the tablets from showing rough surfaces after storage. The disintegrants, however, still require the power sufficient for a rapid disintegration. Scientific investigation has indicated that the disintegration power decreases with decreasing particle size. This can be confirmed by testing our new materials Kollidon CL-F and Kollidon CL-SF. Although these materials have smaller particle sizes, they are still potent disintegrants. Furthermore, in new drug delivery technologies such as oral dispersible tablets, fast disintegrants with very good mouth feeling are in strong demand. Many of these drugs go into pediatric applications and to the OTC market in general, where good patient compliance is a precondition for the success of a drug formulation. Based on these market trends, our customers will now require new disintegrants for their new applications.
4 4 The Products The different Kollidon CL grades can best be distinguished by their different particle sizes: Average particle size range [µm] Kollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M 3 10 All CL-grades are crosslinked, water-insoluble polivinylpyrrolidones. There are chemical but mainly physical crosslinks. In contrast to many other disintegrants, the Kollidon CL grades are non-water-soluble. As a consequence, there is no influence on the disintegration of a tablet and the dissolution of the active due to the increased viscosity. The crospovidones act as disintegrants by absorbing water and subsequently swelling. This gain in volume is responsible for the subsequent disintegration of the tablet. However, the speed of disintegration is not only based on the swelling; * N n * O Chemical names Crospovidone Crospovidonum Insoluble polyvinylpyrrolidone Crosslinked PVP it is a combination of many factors such as: The swelling volume of the disintegrant The swelling pressure of the disintegrant The hydrophilic behavior of the disintegrant The pore sizes within the tablet The mechanical properties of the tablet Chemical crosslinks Entangled polymer chains (N-vinylpyrrolidone-polymer) A highly (mainly physically) crosslinked polymer matrix The chemical structure of Kollidon CL: It is a crosslinked homopolymer of N-vinyl-2-pyrrolidone
5
6 6 The Application In general, there is no perfect disintegrant. Disintegration is strongly dependent on the formulation of the tablet in terms of porosity, method of manufacture (wet or dry granulation) and the use of different actives and other excipients. Comparison of the materials The principle property of the materials is to decrease the disintegration time of tablets. In the figure below the three Kollidon grades are compared with their main competitive materials. Clearly, Kollidon CL shows the strongest performance. Even with a decreased particle size, the new grades Kollidon CL-F and Kollidon CL-SF show good performance, not having some of the drawbacks that Kollidon CL has, as explained above. Apart from the increase in tablet disintegration, it is even more important that the dissolution of the active ingredient is also increased. Disintegration time of direct compressed tablets with different disintegrants (6 % disintegrant in Ludipress LCE, compressed at 18 kn) 02:09 01:55 01:40 time [min:sec] 01:26 01:12 00:57 00:43 00:28 00:14 00:00 Kollidon CL Kollidon CL-F Kollidon CL-SF Crospovidone Competitor A ( µm) Crospovidone Competitor A (30 50 µm) Croscarmellosesodium Sodium starch glycolate
7 The Application 7 Dissolution of acetaminophen in deionized water (2.7 % disintegrant in a wet granulated formulation, compressed at 18 kn) 100 method: paddle 100 rpm; 37 C drug release [%] Kollidon CL Kollidon CL-F Kollidon CL-SF Crospovidone Competitor A ( µm) Croscarmellose-sodium Crospovidone Competitor A (30 50 µm) Sodium starch glycolate time [min] The dissolution curves show that Kollidon CL has the best performance, followed by Kollidon CL-F and Kollidon CL-SF. In some cases customers may wish to have a slightly slower disintegration for specific applications; the new materials could help to produce a dissolution profile fitted to such a requirement, e. g. for generics. A requirement of many customers is that the tablets show a smooth surface after storage in multidose containers. Because the Kollidon CL grades are very hydrophilic, they tend to absorb water and thus produce a rough surface due to swelling. In the case of film tablets, this might cause cracks in the film. Tablets produced with fine materials Kollidon CL-F and Kollidon CL- SF produce a very smooth surface.
8 8 The Application Kollidon CL Kollidon CL Kollidon CL is used as the standard disintegrant for all kinds of fast dispersible tablet formulations. For many years, companies have known just how well the material performs. The main reasons for using Kollidon CL are the advantages provided compared to other materials like e. g. starch or cellulose derivatives. When used as disintegrants, these products tend to form highly viscous systems when in contact with water. This is in contrast to Kollidon CL, which is insoluble and which as a consequence does not slow down the dissolution of a oral dosage form but might even increase the release of the active ingredient. In some cases where Kollidon CL does not meet the requirements of the customers e. g. for wet granulation with a large amount of solvent, Kollidon CL-F or Kollidon CL-SF are suitable replacements µm µm µm Kollidon CL
9 The Application Kollidon CL-F 9 Kollidon CL-F Kollidon CL-F is the perfect alternative when formulators are looking for a disintegrant with strong disintegration power in combination with a smooth tablet surface. With Kollidon CL, however, some problems might occur when the tablet is very hygroscopic and packed in a multi-dose container. Capsules filled with microtablets (capsule size 00 4) 23.5 mm 8.5 mm 5.2 mm 14.1 mm µm µm µm Kollidon CL-F Kollidon CL-F should be used for the development of small tablets when fine particles are required to avoid content uniformity problems. Furthermore, the material is able to absorb large amounts of solvent. This can be beneficial when customers use such large amounts during a wet granulation step where large amounts of solvent are needed e. g. for dissolving the active. However, in some cases, Kollidon CL-SF might be the best solution for a specific application. Microtablets, 2 mm diameter
10 10 The Application Kollidon CL-SF Kollidon CL-SF Kollidon CL-SF has advantages when it comes to special applications, for example oral fast dispersible tablets. The main reason is reliable disintegration power in combination with a very smooth cream-like mouth feel. Nevertheless, in some cases, Kollidon CL-SF might be used as a regular disintegrant when customers have a wet granulation process that uses large amounts of solvent. Kollidon CL-SF has the highest solvent (water/ethanol etc.) uptake capacity of all the crospovidones produced by BASF µm Kollidon CL-SF µm µm
11
12 12 The Examples Formulation of Nifedipine tablets (granulated) Nifedipine 10 mg (5.85 %) Kollidon VA mg (5.85 %) Ludipress LCE 100 mg (58.50 %) Kollidon CL-F or -SF 50 mg (29.22 %) Magnesium stearate 1 mg (0.58 %) Tablet weight 171 mg (100 %) Formulation of Haloperidol tablets (direct tabletting) Haloperidol 2 mg (2.5 %) Ludipress LCE 75 mg (93.75 %) Kollidon CL 2.5 mg (3.12 %) Magnesium stearate 0.5 mg (0.63 %) Tablet weight 80 mg (100 %)
13 The Overview 13 As far as disintegrants are concerned, there are many products in the market starting with the basic starches derived from maize, rice, corn and potato. They have been used for a long time but have certain disadvantages in terms of the amount that is needed to ensure disintegration. One particular disadvantage of disintegrants based on starch and of the cellulose derivatives is the increase of viscosity after disintegration. The first question is always related to the real effect of the disintegrant on the disintegration time. In the figure, the disintegration test results of tablets produced with granulated material are shown. These clearly show the strengths of the crospovidones, especially the Kollidon CL grades. Disintegration of tablets made of granules (2,7 % disintegrant extragranular use, compressed at 18 kn) :56 disintegration time [min] :55 Kollidon CL 11:08 Kollidon CL-F 09:06 Kollidon CL-SF 12:46 12:30 Kollidon CL-M Crospovidone Competitor A ( µm) 22:37 Crospovidone Competitor A (30 50 µm) 23:28 Croscarmellosesodium Sodium starch glycolate
14 14 The Overview Disintegrants on the market Required Disinte- Hardness Issues during % gration power of the tablets storage at 1: low high humidity 10: high Starches Low * Starch derivatives Sodium starch glycolate High Brown spots Cellulose derivatives Carmellose-sodium Croscarmellose-sodium Carmellose-calcium HPC Medium * High Brown spots (most cases 2 3) Medium * High * Crospovidone grades Compet. A ( µm) Compet. A (30 50 µm) Kollidon CL Kollidon CL-F Kollidon CL-SF High Rough surface High Smooth surface Medium Rough surface High Smooth surface Very high Smooth surface *: Not tested
15 The Summary 15 The following table describes the advantages of each material for our customers the pharmaceutical industry and their customers, the patients. Benefits for manufacturers Benefits for patients Main applications Kollidon CL The super-disintegrant, Fast drug absorption Disintegrant for very fast disintegration for most APIs standard tablets Kollidon CL-F No content uniformity Easy to swallow Small tablets, problems especially in due to tablet size tablets stored under small tablets high humidity Kollidon CL-SF Perfect for fast Best mouthfeel Fast dispersible dispersible tablets, tablets, excellent tablet surface intragranular disintegrant for wet granulation Kollidon CL-M Stable dispersions Easy to redisperse Suspensions Depending on the preferred disintegration and dissolution rate, our customers can select the excipient of choice from our comprehensive product range.
16 Please write in block letters. Thank you. Title/Name Department Please apply postage stamp. Company Address Town Country Telephone Fax Reply card BASF Aktiengesellschaft G-MEP/ME Li 554 Attn: Dr. Hubertus Folttmann Carl-Bosch-Straße 64 D Limburgerhof Germany Fax Reply Local contact: or Headquarter Germany: Please complete, copy and fax to us, or detach the postcard and send it to us. Please send the following information: Technical information on Kollidon CL grades. Sample of Kollidon CL, 0.5 kg. Sample of Kollidon CL-F, 0.5 kg. Sample of Kollidon CL-SF, 0.2 kg. Sample of Kollidon CL-M, 0.5 kg. Technical information on Kollidon VA 64. Technical information on Kollidon VA 64 Fine. Technical information on Ludipress. DVD Pharmaceutical Excipients by BASF Fine Chemicals. Newsletter ExAct (Excipients & Actives for Pharma). Please contact me, I would like to know more about Kollidon CL.
17 Please send the following information: Technical information on Kollidon CL grades. Sample of Kollidon CL, 0.5 kg. Sample of Kollidon CL-F, 0.5 kg. Sample of Kollidon CL-SF, 0.2 kg. Sample of Kollidon CL-M, 0.5 kg. Technical information on Kollidon VA 64. Technical information on Kollidon VA 64 Fine. Technical information on Ludipress. DVD Pharmaceutical Excipients by BASF Fine Chemicals. Newsletter ExAct (Excipients & Actives for Pharma). Please contact me, I would like to know more about Kollidon CL. We look forward to answering any questions you may have. Please fill in the postcard, detach it and return it to the address overleaf. Please contact your local BASF company or one of the following regional centers: Asia BASF Asia Pacific Regional HQ Pharma Solutions Dr. Danilo Mercado BASF East Asia Regional Headquarters Ltd. 45th Floor, Jardine House, No.1 Connaught Place, Central, Hong Kong Phone: Fax.: mercadd@ basf-east-asia.com.hk Europe BASF Aktiengesellschaft MEE/HP J 550 Mr. Peter Hoffmann D Ludwigshafen Germany Phone: Fax: peter.01.hoffmann@ basf.com North America BASF Corporation Pharma Solutions Mr. Javier Beeck 100 Campus Drive Florham Park, NJ USA Phone: Fax: javier.beeck@ basf.com South America BASF S.A. Human Fine Chemicals Ms. Vanessa Occhipinti Estrada Samuel Aizemberg, São Bernardo do Campo SP Brazil Phone: Fax: vanessa.occhipinti@ basf.com
18 Excipients Kollidon grades Group of povidone and copovidone products suitable mainly as tablet binders, crospovidone as tablet disintegrant and dissolution enhancer. Kollidon SR Matrix sustained release polymer. Ludipress grades Direct tabletting aids for faster product development and speedier processing. Kollicoat grades Range of aqueous based film formers, cost efficient and ecological. Cremophor grades and Solutol HS 15 Range of different ethoxylated emulsifiers and solubilizers suitable for topical, oral and parenteral formulations. Soluphor P 2-pyrrolidone. Lutrol grades Range of PEGs (Lutrol E range) and poloxamers (Lutrol F range) for a wide variety of pharmaceutical dosage forms. Actives Ephedrines Pseudoephedrines Theophylline Caffeine Isotretinoin Tretinoin Ibuprofen Dobutamine Dopamine Isometheptene mucate Oxymetazoline PVP-Iodine Selegiline Xylometazoline APIs by Orgamol Vitamins Contract Manufacturing Value Added Pharma Solutions by BASF BASF offers more than cgmp quality and supply safety: technical expertise. Our technical service is always at your side. BASF wishes to create a prosperous and sustainable future with you as our customer and partner. BASF Aktiengesellschaft Fine Chemicals Division Pharma Solutions Ludwigshafen Germany Fax pharma.solutions@basf.com BASF the world s leading chemical company can look back on well over 140 years of success and has attained an outstanding position as a reliable partner. Our portfolio for the pharmaceutical industry comprises a comprehensive range of major and new active ingredients and excipient brands. MEMP e-00
19
20
21
22
23
24
25
26
27
28
29
30
Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy
Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy Dr. Philipp Hebestreit, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities.
More informationSoluplus The Solid Solution Opening New Doors in Solubilization.
Soluplus The Solid Solution Opening New Doors in Solubilization. Dr. Shaukat Ali, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities. Custom Synthesis Excipients Active
More informationTECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations
TECHNICAL INFORMATION 1426 RxCIPIENTS FM 1 A versatile excipient for orally disintegrating tablet (ODT) formulations Table of contents 1 Introduction 3 2 Mode of action and advantages of RxCIPIENTS FM
More informationVIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies
VIVAPHARM PVP/VA Copovidone, Ph.Eur. USP/NF, JPE, E 1208, FCC The Ultimate Tablet Binder for All Processing Technologies Direct Compression Dry Granulation Hot Melt Extrusion Wet Granulation VIVAPHARM
More informationSTARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant
EXCIPIENTS STARCH 1500 Proven and Trusted Excipient for Performance and Versatility Effective and economical disintegrant Excellent stability for moisture sensitive drugs Manufactured exclusively for the
More informationExcipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE
Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE Paradigm shift in pharmaceutical development Traditional medicinal products
More informationNew formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability
New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability Andreas Gryczke, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities.
More informationSTARCH Application Data
STARCH 1500 Application Data Partially Pregelatinized Maize Starch Starch 1500, Partially Pregelatinized Maize Starch, Used as a Binder Disintegrant in High Shear Wet Granulation Comparison to Povidone
More informationLibrel. Highly soluble chelates for plant nutrition
Librel Highly soluble chelates for plant nutrition A great mixer, tackling micronutrient deficiencies effortlessly Microgranular Librel range dissolves rapidly and completely and offers unrivalled compatibility
More informationApplication of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products
57. Starch Convention, Detmold, April 26-28, 2006 K.-J. Steffens Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products Starches, Pharmaceutical Applications _ Starches
More informationDirect Compression. With the right ingredients it s a simple, cost-effective manufacturing process
Direct With the right ingredients it s a simple, cost-effective manufacturing process TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Speed and savings sounds good to us
More informationVolker Bühler. Pharmaceutical Technology of BASF Excipients. Pharma Ingredients &Services. Welcome to more opportunities.
Volker Bühler Pharmaceutical Technology of BASF Excipients Pharma Ingredients &Services. Welcome to more opportunities. Volker Bühler Pharmaceutical Technology of BASF Excipients 3 rd revised edition June
More informationEasy, fast and reliable!
Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. Tailormade formulated. s film coating products are one-step coating
More informationExcipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical
Excipient Quality & Trouble Shooting By Seema Trivedi GM, Technical Back Ground The Society for Pharmaceutical Dissolution Science (SPDS) had held its 6th Annual International Convention Disso India -
More informationEasy, fast and reliable!
Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. s film coating products are one-step coating systems for pharmaceutical
More informationThe unlocked synergy of DFE Pharma MCC
The unlocked synergy of DFE Pharma MCC We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder inhalation formulations.
More informationA FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS
Research Article A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS K. P. R. Chowdary *, Tanniru Adinarayana, T. Vijay, Mercy. R. Prabhakhar
More informationCritical material properties for the design of robust drug products : excipient functionality related characteristics
Critical material properties for the design of robust drug products : excipient functionality related characteristics Dr Liz Meehan, Pharmaceutical Development, Macclesfield UK 1 Excipients Definition
More informationDissolution control of direct compression tablets in different test media using novel pregelatinized starch, Swelstar TM MX-1
Dissolution control of direct compression tablets in different test media using novel pregelatinized starch, Swelstar TM MX-1 ASAHI KASEI CHEMICALS CORPORATION CEOLUS R&D DEPARTMENT 1 CONTENTS General
More information7. SUMMARY, CONCLUSION AND RECOMMENDATIONS
211 7. SUMMARY, CONCLUSION AND RECOMMENDATIONS Drug absorption from the gastro intestinal tract can be limited by various factors with the most common one being poor aqueous solubility and poor permeability
More informationTo study the effect that hydroxypropylcellulose (HPC) polymer molecular weight (MW) exerts on drug release rates and mechanism from matrix tablets.
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-029-1 (Supersedes PTR 029) Page 1 of 7 Hydroxypropylcellulose in Modified Release Matrix Systems: Polymer Molecular Weight Controls
More informationBiopharmaceutics Dosage form factors influencing bioavailability Lec:5
Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Ali Y Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School of Pharmacy University of Sulaimani 09/01/2019
More informationPharma Ingredients & Services. Ibuprofen. Technical Information. = Registered trademark of BASF group USP, Ph. Eur., JP
Technical Information Ibuprofen April 2010 Supersedes issue dated January 2010 03_030720e-10/Page 1 of 14 = Registered trademark of BASF group USP, Ph. Eur., JP Pharma Ingredients & Services 03_030720e-10
More informationDVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ
QbD Approach to Formulation of Hydrophilic Matrix Using Sample Kit of Hypromellose [Metolose SR] DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa,
More informationAnimal Health. Premixes Dietary Fibers. and Gels Solid. Dosage Forms. Liquids. Product Overview. Customize Your Formulation
Animal Health Product Overview Liquids and Gels Solid Dosage Forms Premixes Dietary Fibers Customize Your Formulation ANIMAL HEALTH Product Overview General Information Liquids and Gels Healthcare is essential
More informationSUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING
SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING Dr. Dieter Lubda MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany Agenda: Sustained release
More informationEffect of superdisintegrants and their mode of incorporation on disintegration time and release profile of carbamazepine from immediate release tablet
Journal of Applied Pharmaceutical Science Vol. 3 (5), pp. -84, May, 213 Available online at http://www.japsonline.com DOI: 1.7324/JAPS.213.3515 ISSN 2231-3354 Effect of superdisintegrants and their mode
More informationREVISION OF MONOGRAPH ON TABLETS. Tablets
March 2011 REVISION OF MONOGRAPH ON TABLETS Final text for addition to The International Pharmacopoeia This monograph was adopted by the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical
More informationFLORITER. New Technology for Innovative Formulation Design.
FLORITER New Technology for Innovative Formulation Design www.tomitaph.co.jp FLORITE Dramatically Change Your Formulation FLORITE is synthetic Calcium Silicate with exceptional liquid absorbency and excellent
More informationDow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow
Dow Wolff Cellulosics Pharmaceutical Excipients Using ingenuity and savvy to help design healthcare solutions TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Enhancing
More informationFormulation and Evaluation
Chapter-5 Formulation and Evaluation 5.1 OBJECTIVE After successful taste masking and solubility enhancement of drugs in preliminary studies, by using Mannitol Solid Dispersion, next step includes the
More informationHydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems D. Tewari, R. K. Lewis, W. W. Harcum and T Dürig
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-069-1 (Supersedes PTR-069) Page 1 of 8 Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems
More informationKollicoat Smartseal 30 D Active Protection
Pharma Ingredients & Services. Welcome to more opportunities. Custom Synthesis Excipients Active Ingredients Kollicoat Smartseal 3 D Active Protection Breaking new ground in taste masking and moisture
More informationEXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients
EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER Life-saving pharmaceuticals start with high-quality ingredients CONFIDENCE STRAIGHT FROM THE SOURCE From oral dosage excipients (Rx, Gx, nutraceuticals
More informationInt. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:
International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2014; 4(1):47-51 Research Article FORMULATION AND EVALUATION
More information>>> Oral Formulation Optimization. Introduction. A Tiered Approach for Identifying Enabling Formulations
Application Note #28-DMPK-3 >>> Oral Formulation Optimization Introduction Among the criteria required of compounds advancing from drug discovery programs, adequate systemic exposure (plasma concentrations
More informationOptimization of valsartan tablet formulation by 2 3 factorial design
Research Article ISSN: 0974-6943 K. P. R. Chowdary et al. / Journal of Pharmacy Research 2014,8(9, Available online through http://jprsolutions.info Optimization of valsartan tablet formulation by 2 3
More informationA Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac
Asian Journal of Chemistry Vol. 22, No. 6 (2010), 4239-4244 A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac K.P.R. CHOWDARY*
More informationCONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications
Hypromellose CONTENTS PAGE 2 Preface Matrix system Selection of METOLOSE grades Specifications Properties Powder Solution Application Related Patents 3 4-5 6 8 10 13 14 17 Please note: The information
More information4. Monitoring of dissolution induced changes in film coat
4. Monitoring of dissolution induced changes in film coat composition 4.1 Introduction As membrane controlled drug delivery coatings are subjected to changes in coating composition, it is necessary to
More informationANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section.
2. EXCIPIENTS PROFILES ANNEXURE -2 Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section. 2.1. COMPRITOL 888 Non proprietary names BP:
More informationRationale of and Experience with the Expert System
Rationale of and Experience with the Expert System Professor Mitsuru HASHIDA Roland DAUMESNIL Lecture presented during the Controlled Release Society Symposium Optimization of Oral Drug Delivery Hong Kong
More informationSTUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS
Int. J. Chem. Sci.: 10(4), 2012, 1934-1942 ISSN 0972-768X www.sadgurupublications.com STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS K. VENUGOPAL * and K. P. R. CHOWDARY a Nirmala College
More informationLYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating
LYCOAT New solutions for Film Coating from Roquette LYCOAT for quicker quality coating Roquette LYCOAT New solutions for Film Coating from Roquette LYCOAT New solutions for Film Coating Film coating, the
More informationCHEWABLE SOFTGEL TECHNOLOGY
CHEWABLE SOFTGEL TECHNOLOGY PROCAPS AT A GLANCE Procaps is a Pharmaceutical Group dedicated to delivering innovation, health and Nutrition. We work hand in hand with our customers and develop products
More informationYOUR ORAL SOLID DOSE. In pursuit of excipient excellence
YOUR ORAL SOLID DOSE DFE Pharma globally supplies a unique, broad portfolio of key excipients including lactose, MCC, superdisintegrants and starches. Innovative products such as SuperTab 24AN and SuperTab
More informationKolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.
Technical Information Kolliwax HCO September 2015 03_150617e_00/Page 1 of 8 WF-No. 129938 = Registered trademark in many countries Hydrogenated castor oil powder for pharmaceutical use 03_150617e_00 September
More informationCombining HME & Solubilization: Soluplus - The Solid Solution By: Hendrik Hardung, PhD; Dejan Djuric, PhD; and Shaukat Ali, PhD
Combining HME & Solubilization: Soluplus - The Solid Solution By: Hendrik Hardung, PhD; Dejan Djuric, PhD; and Shaukat Ali, PhD INTRODUCTION Drug solubilization has drawn attention in recent years because
More informationFormulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium
Available online on www.ijddt.com International Journal of Drug Delivery Technology 214; (3); 98-13 Research Article ISSN: 97 441 Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast
More informationAsian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012
STUDIES ON EFFECT OF SUPERDISINTEGRANTS ON ETORICOXIB TABLET FORMULATIONS Chowdary K. P. R 1, Venugopal. K *2 1 College of Pharmaceutical Sciences, Andhra University, Vishakapattanam. 2 * Nirmala college
More informationGlobal Oilfield Solutions. Demulsifiers for the Oil Industry: Basorol
Demulsifiers for the Oil Industry: Basorol The most important objective of any oil production facility is the separation of water from produced crude. The quick and efficient breaking of these emulsions
More informationInternational Journal of Pharma and Bio Sciences V1(1)2010 FORMULATION AND EVALUATION OF ROSIGLITAZONE MOUTH DISSOLVING TABLET
G ARJUN 1*, M.SRAVAN PRASAD 1, D SANTHOSHA 1 AND G.ACHAIAH 2 1 Nalanda college of pharmacy, Osmania University, Nalgonda, India. 2 University College of Pharmaceutical Sciences, Kakatiya University, Warangal,
More informationFORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES
Int. J. Chem. Sci.: 10(1), 2012, 297-305 ISSN 0972-768X www.sadgurupublications.com FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES K. P.
More informationFormulation and Development of Sustained Release Tablets of Valsartan Sodium
INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Research Article Formulation and Development of Sustained Release Tablets of Valsartan Sodium G. Sandeep * and A. Navya Department of
More informationEvaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig
PHARMACEUTICAL THNOLOGY REPORT Consumer Specialties ashland.com PTR 11 Page 1 of 5 Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig Objectives When preparing tablets by roller
More informationFormulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride.
Available online on www.ijcpr.com International Journal of Current Pharmaceutical Review and Research, 3(4), 105-109 Research Article ISSN: 0976-822X Formulation and Evaluation of Gastroretentive Dosage
More informationSUMMARY AND CONCLUSION
SUMMARY AND CONCLUSION 8 SUMMARY AND CONCLUSIONS In spite of the many challenges faced by researchers while designing an effective, reproducible and stable dosage form, oral dosage forms continued to maintain
More informationSENTRY TM POLYOX Water Soluble Resins
SENTRY TM POLYOX Water Soluble Resins Technical Information on Stability Introduction Key Points Antioxidants SENTRY POLYOX WSR resins consist of a family of high molecular weight polyethers with nominal
More informationResearch Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution of Topiramate Immediate Release Tablets
International Journal of Pharmaceutical Sciences and Nanotechnology Volume 2 Issue 2 July September 2009 Research Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution
More informationThe Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation
METHOCEL Premium Cellulose Ethers Application Data The Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation INTRODUCTION Hydrophilic matrices
More informationFROM SOLVENT TO AQUEOUS COATINGS. (Out of the Frying Pan...) Ralph E. Pondell. Coating Place, Inc. P.O. Box
84-1 FROM SOLVENT TO AQUEOUS COATINGS (Out of the Frying Pan...) Ralph E. Pondell Coating Place, Inc. P.O. Box 930310 Verona, WI 53593 A number of reasons exist for the current high level of interest in
More information(12) Patent Application Publication (10) Pub. No.: US 2003/ A1
US 2003.01.18647A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0118647 A1 Seth (43) Pub. Date: (54) EXTENDED RELEASE TABLET OF Publication Classification METFORMIN (51)
More informationCo-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009
Co-Processed Excipients: Regulatory Challenges Carl Mroz Colorcon Limited June 2009 What is a Co-Processed excipient? Several types of excipient contain multiple components by design Use of processing
More informationStudies of Rapidly Disintegrating Tablets in the Oral Cavity Using Co-ground Mixtures of Mannitol with Crospovidone
February 2002 Chem. Pharm. Bull. 50(2) 193 198 (2002) 193 Studies of Rapidly Disintegrating Tablets in the Oral Cavity Using Co-ground Mixtures of Mannitol with Crospovidone Toshifusa SHU,* Hideshi SUZUKI,
More informationGLYCOLYS
ROQUETTE WORLDWIDE EUROPE FRANCE Roquette Frères Corporate Headquarters 62080 Lestrem cedex - France Telephone: + 33 3 21 63 36 00 Fax: + 33 3 21 63 38 50 FINLAND Roquette Nordica Oy PL 11 P.O.B FIN-02171
More informationFormulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch
Abstract K.P.R. Chowdary et al. / International Journal of Pharma Sciences and Research (IJPSR) Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch K.P.R. Chowdary*,
More informationSCIENTIFIC DISCUSSION
SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredients (APIs): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:
More informationContinuous Granulation Using a Twin-Screw Extruder. Lin Zhu, Ph.D. Manufacture Science and Technology AbbVie June, 2016
Continuous Granulation Using a Twin-Screw Extruder Lin Zhu, Ph.D. Manufacture Science and Technology AbbVie June, 2016 What is a twin screw extruder and how to use it for continuous granulation? Dry feed:
More informationInt. Res J Pharm. App Sci., 2012; 2(6): ISSN:
Review Article International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2012; 2(6): 207-213 A CONCISE REVIEW ON NOVEL
More informationFORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD
Int. J. Chem. Sci.: 6(3), 2008, 1270-1275 FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD K. P. R. CHOWDARY, P. TRIPURA SUNDARI and K. SURYA
More informationFormulation and evaluation of oro-dispersible tablets of lafutidine
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):226-235 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationBioavailability enhancement of poorly soluble APIs. Enhanced solubilization out of solid glassy solutions prepared by Hot-Melt Extrusion
Pharma Ingredients & Services. Welcome to more opportunities. Custom Synthesis Excipients Active Ingredients ExActConcepts Example: Itraconazole Bioavailability enhancement of poorly soluble APIs Enhanced
More informationDevelopment of USP Delayed Release Aspirin Tablets using Opadry Enteric, Acrylic-Based Coating System
Opadry Enteric Application Data Acrylic-Based Coating System Development of USP Delayed Release Aspirin Tablets using Opadry Enteric, Acrylic-Based Coating System INTRODUCTION Acetylsalicylic acid (aspirin)
More informationCHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION
CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION LEARNING OBJECTIVES The objectives of this unit are to: Understand the formulation of solid dosage form. Understand the characteristic
More informationLubriTose Mannitol Michael Crowley, Director of R&D, Excipients
LubriTose Mannitol Michael Crowley, Director of R&D, Excipients Introduction Michael Crowley Director of R&D Excipients 158 St. Highway 320 Norwich, NY 13815 PH 315-802-5970 Michael.Crowley@Kerry.com 2
More informationPharma & Food Solutions. POLYOX TM Water Soluble Resins Combining Flexibility with Consistency
Pharma & Food Solutions POLYOX TM Water Soluble Resins Combining Flexibility with Consistency POLYOX 9-13 POLYOX 9-13 POLYOX * are nonionic poly (ethylene oxide) polymers that meet all the specifications
More information(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )
(19) TEPZZ 94677_A_T (11) (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 2.11.1 Bulletin 1/48 (1) Int Cl.: A61K 9/ (06.01) A61K 31/41 (06.01) (21) Application number: 116790.3 (22) Date of
More informationFORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES
Volume: 2: Issue-4: Oct - Dec -2011 ISSN 0976-4550 FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER 407 - PVPK30 INCLUSION COMPLEXES K.P.R. Chowdary*, K. Surya Prakasa
More informationInnovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017
Innovations in Design: NIA-West Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017 1 Innovations in Design: How Do You Stand Out? If all other competitors are the same
More informationInt. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN:
International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2013; 3(6):42-46 Research Article ENHANCEMENT OF SOLUBILITY
More informationTechnical brochure StarLac
T R TABLETING AC DIRECT COMPRESSION CO-PROCESSED LACTOSE Technical brochure MEGGLE co-processed lactose grades for direct compression: General information Direct compression (DC) tablet manufacture is
More informationSCIENTIFIC DISCUSSION
This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1
More informationDesign and In-vitro Evaluation of Silymarin Bilayer Tablets
CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original Article Design and In-vitro Evaluation of Silymarin
More informationENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE
PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE Kantilal B. Narkhede *1, R. B. Laware 2, Y. P.
More informationDESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN
Int. J. Chem. Sci.: 10(4), 2012, 2199-2208 ISSN 0972-768X www.sadgurupublications.com DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN K. V. R. N. S. RAMESH *, B. HEMA KIRNAMAYI
More information( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / A1
THE LETTERIN US 20170231969A1 MUTTU 19 United States ( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / 0231969 A1 Raneburger et al. ( 43 ) Pub. Date : Aug. 17, 2017 ( 54 ) PHARMACEUTICAL
More informationInt. Res J Pharm. App Sci., 2012; 2(6): ISSN:
International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2013; 3(1): 269-273 Research Article FORMULATION DEVELOPMENT
More informationSTARCHES FOR COSMETIC INDUSTRIES CORN PO4 PH B AND RICE NS
STARCHES FOR COSMETIC INDUSTRIES CORN PO4 PH B AND RICE NS AGRANA STARCH QUALITATIVE OPTIMIZATION OF COSMETIC EMULSIONS WITH CORN PO4 PH B OR RICE NS For many years CORN PO4 PH B and RICE NS (cross-linked
More informationFORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE CONTAINING MULTICOMPONENT INCLUSION COMPLEX
Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 4, Issue 1, 2012 Research Article FORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE
More informationAvailable Online through Research Article
ISSN: 0975-766X Available Online through Research Article www.ijptonline.com DESIGN AND EVALUATION OF GASTRORETENTIVE TABLETS FOR CONTROLLED DELIVERY OF NORFLOXOCIN Ganesh Kumar Gudas*, Subal Debnath,
More informationEnhanced delivery methods for greater efficacy
On-Line Formulation Training - Anywhere In The World - Enhanced delivery methods for greater efficacy Belinda Carli Director, Institute of Personal Care Science Image showing absorbance in the outer stratum
More informationLIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)
November 2007 LIQUID PREPARATIONS FOR ORAL USE Final text for addition to The International Pharmacopoeia (November 2007) This monograph was adopted at the Forty-second WHO Expert Committee on Specifications
More informationKURARAY POVAL & EXCEVAL
Characteristics Polyvinyl alcohol (PVOH) having varying degree of polymerization and. Recommended Uses Ranging from emulsion polymerization aid to binder for pigments in paper applications. Form supplied
More informationThe binding performance of DFE Pharma Starch
The binding performance of DFE Pharma Starch MCC Starch Lactose Inhalation Superdisintegrants We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients
More informationFolic Acid in Human Nutrition
Folic Acid in Human Nutrition Folic acid is a water soluble B vitamin widely distributed in foods. Deficiencies lead to impaired cell division and altered protein synthesis. Newborn children of women receiving
More informationEffect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs
Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs James E. Polli jpolli@rx.umaryland.edu April 26, 2016 Topics BCS Class 3 excipient study
More informationFunctional Excipients for Suppository Applications
Functional Excipients for Suppository Applications Skin Delivery Platform 2016 1 The Skin Delivery Platform Major areas of activity are in 4 pillars PLATFORM : SKIN DELIVERY Dermal Drug Delivery Mildness
More informationTable 1 Hydrophilicity of MC and HPMC Grades. Polymer Cloud Point ( C) Hydrophilicity MC HPMC Type 2910 HPMC Type
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-046-1 (Supersedes PTR-046) Page 1 of 6 Effect of Hypromellose and Methylcellulose Substitution Type, Molecular Weight and Drug Solubility
More informationUniversity of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester
University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester 5/21/2017 Pharmaceutical Compounding, Dr. rer. nat. Rebaz Ali 1 Outlines Why rectal or vaginal route? Suppository
More informationSCIENTIFIC DISCUSSION. Efavirenz
SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredient (API): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:
More information